Medindia

X

For the First Time, Alzheimer's Drug Will be Funded in NZ

by Rajshri on  May 6, 2010 at 9:55 PM Drug News   - G J E 4
Drug-buying agency Pharmac has announced that for the first time a medicine specifically targetting Alzheimer's Disease and dementia will be funded in New Zealand.
 For the First Time, Alzheimer's Drug Will be Funded in NZ
For the First Time, Alzheimer's Drug Will be Funded in NZ
Advertisement

Pharmac revealed that it plans to buy the Donepezil Rex brand of medicines after the drug is registered with medicines safety regulator Medsafe. This decision was made because evidence indicates drugs belonging to the class of acetylchlorinesterase inhibitors may slow the progression of Alzheimer's in some patients.

Advertisement
Donepizil will become available without restriction to an estimated 15,000 people in the country after Pharmac managed to reduce the $32 million price tag on the drug by 95%.


Source: Medindia
RAS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All